Literature DB >> 27458248

Implications of the Bystander and Abscopal Effects of Radiation Therapy.

Vivek Verma1, Steven H Lin2.   

Abstract

Siva and colleagues have demonstrated that localized thoracic radiation resulted in DNA damage at out-of-field sites. Although these interesting findings require validation, we discuss the important clinical implications of these data, especially in the era of immune therapies. Clin Cancer Res; 22(19); 4763-5. ©2016 AACRSee related article by Siva et al., p. 4817. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27458248     DOI: 10.1158/1078-0432.CCR-16-1512

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  4 in total

1.  Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer.

Authors:  Vivek Verma; Joe Y Chang
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

2.  Anti-PD-L1 antibody direct activation of macrophages contributes to a radiation-induced abscopal response in glioblastoma.

Authors:  Chibawanye I Ene; Shannon A Kreuser; Miyeon Jung; Huajia Zhang; Sonali Arora; Kara White Moyes; Frank Szulzewsky; Jason Barber; Patrick J Cimino; Hans-Georg Wirsching; Anoop Patel; Paul Kong; Timothy R Woodiwiss; Sharon J Durfy; A McGarry Houghton; Robert H Pierce; Ian F Parney; Courtney A Crane; Eric C Holland
Journal:  Neuro Oncol       Date:  2020-05-15       Impact factor: 12.300

3.  Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy.

Authors:  Shuo Wang; Dandan Zheng; Chi Lin; Yu Lei; Vivek Verma; April Smith; Rongtao Ma; Charles A Enke; Sumin Zhou
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

Review 4.  Acute and Late Toxicities of Concurrent Chemoradiotherapy for Locally-Advanced Non-Small Cell Lung Cancer.

Authors:  Vivek Verma; Charles B Simone; Maria Werner-Wasik
Journal:  Cancers (Basel)       Date:  2017-09-08       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.